Background and Purpose-The annual risk of ischemic stroke distal to Ն50% asymptomatic carotid stenoses was Ϸ2% to 3% in early cohort studies and subsequent randomized trials of endarterectomy. This risk might have fallen in recent years owing to improvements in medical treatment, but there are no published prognostic data from studies initiated within the last 10 years. Methods-In a population-based study of all patients with transient ischemic attack (TIA) or stroke in the Oxford Vascular Study, we studied the risk of TIA and stroke in patients with Ն50% contralateral asymptomatic carotid stenoses recruited consecutively from 2002 to 2009 and given intensive contemporary medical treatment. Results-Of 1153 consecutively imaged patients presenting with stroke or TIA, 101 (8.8%) had Ն50% asymptomatic carotid stenoses (mean age, 75 years; 39% women; 40% age Ն80 years). During 301 patient-years of follow-up (mean, 3 years), there were 6 ischemic events in the territory of an asymptomatic stenosis, 1 minor stroke (initially 50% to 69% stenosis), and 5 TIAs (2 initially 50% to 69% stenosis; 3 to 70% to 99% stenosis), 3 of which led to subsequent endarterectomy. The average annual event rates on medical treatment were 0.34% (95% CI, 0.01 to 1.87) for any ipsilateral ischemic stroke, 0% (95% CI, 0.00 to 0.99) for disabling ipsilateral stroke, and 1.78% (95% CI, 0.58 to 4.16) for ipsilateral TIA. Conclusions-In the first study of the prognosis of Ն50% asymptomatic carotid stenosis to be initiated in the last 10 years, the risk of stroke on intensive contemporary medical treatment was low. Larger studies are required to determine whether this apparent improvement in prognosis is generalizable. (Stroke. 2010;41:e11-e17.)
T he prevalence of stenosis of the proximal carotid arteries increases from the fifth decade of life onward and affects Ϸ7% of women and Ͼ12% of men older than 70 years. 1 Patients with asymptomatic carotid stenoses are at increased risk of ipsilateral carotid territory ischemic stroke 2,3 and of acute coronary events and vascular death. 4, 5 In previously published randomized trials, carotid endarterectomy (CEA) reduced the risk of ipsilateral carotid territory ischemic stroke during the next few years by Ϸ50%, although the absolute risk reduction was low (Ϸ1% per year), and there was uncertainty about benefit in women. 3 Benefit from surgery depends on achieving a low operative risk, and there is some evidence that the operative risk in routine clinical practice is higher than that in large, randomized, controlled trials. 6, 7 It has also been suggested that the risk of stroke associated with best medical treatment might now be lower than in the 3 large randomized trials, 2, 7, 8 which recruited subjects between 1983 and 2003. In a recently published systematic review, Abbott 9 was able to show that the risk of ipsilateral and any-territory stroke in patients with asymptomatic carotid stenoses with medical intervention alone has fallen since the mid-1980s. Taken together with evidence that there has been no similar reduction in the operative risk of CAE in recent years, 10 it is possible that the absolute benefit from CAE for asymptomatic stenosis will now be even smaller than in the previous randomized trials. However, there are very few studies of the risk of stroke distal to asymptomatic stenoses managed by what would now be regarded as best medical treatment. The 2 most recent published studies were both initiated in 1996, 11, 12 but the benefit of statin treatment in older patients, for example, was only demonstrated convincingly with the publication of the results of the Heart Protection Study in 2004. 13 In the absence of any published prognostic data on asymptomatic stenosis from studies initiated within the last 10 years, we performed a prospective, population-based, cohort study of the risk of ipsilateral stroke in patients with Ն50% asymptomatic carotid artery stenosis identified after investigation for transient ischemic attack (TIA) or minor ischemic stroke in another territory and who were therefore on intensive contemporary medical treatment.
Subjects and Methods
The study was nested within the Oxford Vascular Study (OXVASC), a population-based study of all acute vascular events in a population of Ϸ91 000 individuals registered with 63 primary care physicians in 9 general practices in and around Oxford, UK. Methods of OXVASC have been reported previously 14, 15 and were approved by the local research ethics committee. In brief, multiple overlapping methods of "hot" pursuit were used to achieve near-complete ascertainment of all individuals with TIA or stroke. These included an urgent neurovascular clinic to which participating general practitioners and the local accident and emergency department send all individuals with suspected TIA or stroke whom they would not normally admit to hospital; daily assessment of admissions to the medical, stroke, neurology, and other relevant hospital wards; and daily searches of the local accident and emergency department attendance register. To not miss patients who presented late, were referred to other services, or were not referred to secondary care, we also performed monthly computerized searches of family doctor diagnostic coding, hospital discharge codes, and all cranial and carotid imaging studies performed in local hospitals.
Consecutive patients with TIA or stroke, either admitted to hospital or seen in the OXVASC outpatient clinic between April 1, 2002, and March 31, 2009, were considered for inclusion in this study. Stroke was defined as the sudden onset of a focal neurologic deficit lasting Ͼ24 hours without any evidence for other underlying diseases being potentially responsible for the neurologic deficit (eg, brain tumor). TIA was defined as an episode with strokelike symptoms lasting Ͻ24 hours.
All patients gave informed consent and were seen by study physicians as soon as possible after their initial presentation. Event characteristics and risk factors were recorded, and all cases were subsequently reviewed by the study senior neurologist. All patients received intensive contemporary medical intervention, including antiplatelet agent(s), usually aspirin and/or clopidogrel, for the first 30 days and then usually aspirin and dipyridamole thereafter. Furthermore, all patients were treated with a statin, most commonly simvastatin 40 mg daily, unless contraindicated. Antihypertensive medication was initiated or increased in all patients whose blood pressure was Ͼ130/80 mm Hg at baseline or during follow-up. Blood glucose was measured in all patients, and further investigation or treatment was arranged as appropriate. All patients were given advice on lifestyle, particularly the need to stop smoking if relevant.
Carotid ultrasonography was performed by an experienced vascular technician using an ATL Ultramark HDI 5000 scanner. Some patients underwent contrast-enhanced magnetic resonance angiography instead of carotid ultrasonography (Philips Achieva 1.5-T scanner with a neurovascular coil). Stenosis was classified by the NASCET method of measurement of carotid stenosis. 16 Asymptomatic carotid stenosis was defined as a Ն50% diameter reduction of the carotid artery without evidence of any previous stroke or TIA in the territory of the apparently asymptomatic carotid artery.
Analysis was restricted to patients with a TIA or an ischemic stroke with a National Institutes of Health Stroke Scale (NIHSS) score Յ5 at the time of first assessment to facilitate high rates of face-to-face follow-up, of CAE on the recently symptomatic side, and of compliance with intensive contemporary medical intervention. Otherwise, all patients with an asymptomatic carotid bifurcation stenosis of Ն50% were included in the analysis. Carotid occlusions, proximal common carotid stenoses, and distal internal carotid stenoses were excluded. In patients who had presented with a posterior circulation TIA or stroke and had asymptomatic stenoses of both carotid arteries, the artery with the most severe stenosis was included in the analysis.
To ensure that any apparently asymptomatic stenosis was truly asymptomatic, we specifically asked all patients about any previous TIA or stroke and searched hospital records to identify previous events referred to secondary care. Patients also consented to allow us to search their primary care medical records to identify previous events that had not been referred to secondary care in Oxfordshire or that had been investigated elsewhere. Patients were followed up face to face at 30 days, 6 months, 1 year, 2 years, and 5 years by a study nurse or physician. Patients were asked about recurrent symptoms, medications, and disability scores. All recurrent strokes that presented to medical attention would also be identified acutely by ongoing daily case ascertainment within OXVASC. All patients with recurrent events were reassessed by a study physician and reviewed by the senior neurologist. Vascular territory was assessed by the study neurologist who first assessed the patient and subsequently by the senior neurologist.
Risk of TIA or stroke distal to the asymptomatic carotid stenosis was determined from the date that the stenosis was identified on vascular imaging, which was usually a few days after their presenting TIA or stroke. Any TIA or stroke that occurred in association with CAE or stenting of the recently symptomatic stenosis was included in the analysis, as were any events associated with any subsequent CAE or stenting for the asymptomatic stenosis.
Results
Of 1256 patients with a TIA or an ischemic stroke with an NIHSS score Յ5 in OXVASC between April 1, 2002, and March 31, 2009 , 1153 (92%) underwent carotid imaging. Initial imaging was performed with ultrasound in 1118 and with contrast-enhanced magnetic resonance angiography in 35 patients. The main reasons for nonimaging (nϭ103) were that patients did not attend the appointment, they were seen at home and were too frail to come to hospital or they refused further investigation, they had another event or died before the investigation, and was uncertain in 5 cases. An additional 124 patients underwent carotid imaging, of whom 103 had an NIHSS score Ն6 and 21 patients had carotid occlusion and were therefore excluded from further analysis as described earlier.
Of the 1153 imaged patients, 177 had Ն50% stenosis of at least 1 carotid bifurcation, of whom 109 had Ն50% symptomatic carotid stenoses and 101 had a Ն50% asymptomatic carotid stenosis. Of these 101 patients, 75 presented with a contralateral carotid territory TIA or stroke (as opposed to a posterior circulation event), of whom 33 also had Ն50% contralateral symptomatic stenosis and 3 had symptomatic carotid occlusion. Clinical characteristics are shown in Table 1 . Sixty-nine patients had 50% to 69% asymptomatic carotid stenosis and 32 had 70% to 99% asymptomatic stenosis. Mean follow-up was 3.0 years (range, 1 to 84 months), with a total of 301 patient-years of follow-up before stroke or death. Of the 33 patients who had Ն50% symptomatic and asymptomatic carotid stenoses, 25 underwent CAE for the symptomatic stenosis early during follow-up. Only 1 patient underwent CAE for asymptomatic stenosis during follow-up, and no patients underwent angioplasty/stenting. Two patients underwent coronary artery bypass surgery during the observation time. Table 2 shows medication use and control of blood pressure at 1, 12, and 24 months of follow-up. Almost all (97%) patients were on antithrombotic treatment at 1 and 12 months of follow-up, and 96% were on antithrombotic treatment at 24 months of follow-up. Eighty-six percent were taking a statin at 1 month; 83%, at 12 months; and 81%, at 24 months. Eighty-eight percent were taking at least 1 blood pressure-lowering agent at 1 month; 85%, at 12 months; and 82%, at 24 months. At the 5-year follow-up, 94% of patients were on antithrombotic treatment, 79% were on a statin, and 84% were on at least 1 blood pressure-lowering agent.
There were 6 ischemic events in the territory of an asymptomatic stenosis during follow-up: 1 minor stroke (initially 50% stenosis) and 5 TIAs (2 initially 50% to 69% stenosis; 3 to 70% to 99% stenosis). The average annual risks were 0.34% (95% CI, 0.01 to 1.87) for any ipsilateral carotid territory ischemic stroke, 0% (95% CI, 0.00 to 0.99) for disabling ipsilateral carotid territory ischemic stroke, and 1.78% (95% CI, 0.58 to 4.16) for ipsilateral carotid territory ischemic TIA (Table 3 ). Figure 1 shows the Kaplan-Meier hazard curves for risk of ipsilateral carotid territory TIA or stroke. Three patients subsequently underwent CAE for these now-symptomatic stenoses. Reimaging was performed at the time of the ipsilateral event in 4 patients (1 stroke, 3 TIAs), none of whom had an increase in severity of the previously asymptomatic stenosis.
Of the 25 patients who underwent CAE for a symptomatic carotid artery stenosis, 1 had a periprocedural ipsilateral stroke and 3 patients had periprocedural ipsilateral TIAs (no events occurred ipsilateral to the asymptomatic carotid stenosis). Of the 3 patients who had CAE after a stroke or TIA ipsilateral to a previously asymptomatic carotid stenosis, 1 
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patient had a periprocedural ipsilateral stroke. In our cohort of patients with asymptomatic carotid stenoses, the average annual risk rates for vascular events other than ipsilateral stroke or TIA ( 
Discussion
Although the sample size of our study was relatively small, we consider the data useful for several reasons. First, it is a first-ever, population-based, prospective study of the prognosis of asymptomatic stenosis in patients with TIA or stroke in another vascular territory. This group of patients is interesting to study because they are very likely to be prescribed the best medical intervention. They are also clinically important, because in the absence of widespread population screening in most countries, they account for a significant proportion of all patients in whom CAE or stenting for asymptomatic carotid stenosis is considered in routine clinical practice. Second, there are no published studies on the prognosis of asymptomatic stenosis initiated within the last 10 years, during which time there have been improvements in best medical intervention. Third, all patients were followed up face to face as well as by review of primary and secondary care medical records, such that we were very unlikely to have missed stroke events and were able to identify TIAs during follow-up. Fourth, by nesting the study in a population-based TIA and stroke incidence study with near-complete case ascertainment and with no exclusion by age, we were able to include many elderly and frail patients, which avoided any inclusion bias that might have led to underestimation of the risk of stroke. Finally, given the very low rates of CAE for asymptomatic stenosis in the United Kingdom, we were very nearly able to study prognosis without invasive intervention, with only 1 patient undergoing CAE of an asymptomatic stenosis during follow-up. The average annual risk of ipsilateral stroke and/or TIA in patients with asymptomatic Ն50% carotid stenosis on intensive contemporary medical intervention was very low, albeit with relatively wide CIs. Larger studies are required, but our results are consistent with those of 2 other studies initiated in the 1990s and published during the last few years. 11, 12 Figure  2 shows the average annual risk rates of stroke distal to 50% to 99% asymptomatic stenoses from the most relevant published studies that reported information on annual risk rates for stroke in patients with asymptomatic carotid stenosis. However, these studies were heterogeneous in their methodology, differentiation of clinical information provided, and statistical analysis. Most studies did not differentiate between hemorrhagic and ischemic stroke, and some studies did not differentiate between ipsilateral and any stroke. Of note, the only sufficiently large studies that reported an annual risk of stroke Ͻ1.5% recruited patients during the last 10 to 15 years. 11, 12 The lower risk of stroke in more recent studies is perhaps clearer when the exact recruitment and follow-up periods are taken into account (Figures 2b and 2c) rather than just the date of publication (Figure 2a) .
The low risk of ipsilateral ischemic stroke in our patients with significant asymptomatic stenosis is very likely to be due to some extent to intensive medical intervention, particularly the use of statins and blood pressure-lowering medication. Carotid disease appears to gain particular benefit from statin treatment. In the Heart Protection Study, patients with a baseline history of stroke or TIA (any vascular territory) or carotid surgery/stenting who were randomized to simvastatin 40 mg were half as likely as those randomized to placebo to have undergone CAE or angioplasty during follow-up. 17 Similar results were found in the SPARCL trial, with patients randomized to atorvastatin (rather than placebo) being less likely to undergo a revascularization procedure (coronary, carotid, or peripheral) during follow-up. 18 In a SPARCL substudy, it was shown that later carotid revascularization was reduced by 56% in the group randomized to atorvastatin. 19 The reduction in coronary event rates and all recurrent stroke was lower in both trials, which is also consistent with the high rate of vascular events in other territories in our study. In contrast to the very high rate of use of statins in our cohort, only 17% of patients recruited in ACST from 1993 to 1996 were on lipid-lowering therapy at study entry. Although this rate increased to 58% in those recruited from 2000 to 2003, many patients were on what would now be regarded as subtherapeutic doses (eg, simvastatin 10 mg daily). 20 ASED did not report data about statin use at study entry, 11 and only 45% of patients in SMART were on statin treatment at entry. 12 The average annual risk of stroke in vascular territories other than that of the asymptomatic stenosis was relatively high in our analysis (8.32%). However, for various reasons, our cohort was different from others in other randomized trials and general stroke incidence studies, which could explain this relatively high risk. First, all of our patients had extensive large-artery disease with carotid and/or vertebrobasilar stenoses Ն50%. Second, we also included the early risk of stroke in our analysis, unlike many previous randomized clinical trials. Third, we used a very rigorous definition for stroke by including all minor and nondisabling events as well as major and disabling ones.
Our study does have a number of shortcomings. First, the number of patients with asymptomatic carotid stenoses (nϭ101) was not sufficiently large to provide narrow CIs around the estimate of average annual risk of ipsilateral stroke. However, it can be argued that a small but methodologically rigorous study without selection bias provides more reliable data than does a large study with various potential selection biases. As detailed earlier, we are unlikely to have underestimated risk because of our inclusion of "symptomatic" patients, irrespective of age, and our frequent face-to-face follow-up. As was shown in the ACAS trial, many patients with known asymptomatic stenoses do not report TIAs or minor strokes to medical attention, such that these events were only identified at the next scheduled face-to-face follow-up, despite the fact that patients were repeatedly requested to report all events immediately. 21 It is also interesting to note that the similarly small studies published in the 1980s and 1990s reported risk estimates that 
Marquardt et al Low Stroke Risk in Asymptomatic Carotid Stenosis e15
were highly consistent with larger cohort studies and randomized trials that were performed in the same era ( Figure 2) . Second, the majority of patients had only 50% to 69% stenosis, with about a third of our patients having an asymptomatic carotid stenosis of 70% to 99%. However, in contrast to symptomatic carotid stenosis, [22] [23] [24] there is little evidence that the risk of stroke increases with degree of stenosis across the 50% to 99% range. 20, 25 Third, we studied patients with TIA or minor stroke rather than completely asymptomatic patients. However, as mentioned earlier, this is the group in whom asymptomatic carotid stenosis is most commonly found and accounts, in many countries, for the majority of CAEs for asymptomatic stenosis, and some were included in ACAS and in ACST. Moreover, because all included patients had severe large-artery disease, this group should, if anything, have a higher risk of stroke than do truly asymptomatic patients, if one assumes similar intensity of medical treatment. Third, we were unable to include all patients in our study who had a stroke or TIA in a territory other than that of the asymptomatic carotid stenosis because 8% of patients did not undergo vascular imaging, mainly because they were too frail to attend a hospital appointment. However, with 92% we achieved an overall relatively high imaging rate. It is certainly possible that a small selection bias could have resulted from not including patients who did not undergo imaging. However, in any previous study, these 8% of patients who did not undergo investigation would also have not been included because they would not have been identified. We were only able to identify these patients because of the population-based setting of our study. Furthermore, owing to their general condition, these patients would have been unlikely to be eligible for CAE or stenting. Finally, because patients had had a previous TIA or stroke and because they were being followed up, it could be argued that patients who subsequently developed an ipsilateral TIA during follow-up were more likely to be identified and have a CAE for their now-symptomatic carotid stenosis than would be likely in truly asymptomatic patients. However, because only 3 patients with a TIA subsequently underwent CAE during follow-up and 2 of these presented to medical attention independently of the OXVASC study follow-up, substantial bias due to our follow-up is unlikely. Moreover, previous research in our cohort has shown that patients with previous TIA or stroke do not seek medical attention after recurrent TIA any more quickly than do patients with incident TIA. 26 If other studies confirm the low risk of stroke due to asymptomatic stenosis after intensive contemporary medical intervention alone, then this improvement in prognosis will have major implications for routine clinical practice. The benefit from CAE for asymptomatic carotid stenosis in the previous large trials was already small 20, 25 and was very dependent on low operative risk. 27 There is already evidence that the operative risk of CAE in routine clinical practice is significantly higher than that seen in the trials. 28 For example, a systematic review of operative risks in surgical case series that published operative risks for asymptomatic stenosis shortly after ACAS reported that operative mortality was 8 times higher than in ACAS (1.11% vs 0.14%, Pϭ0.01) and that the risk of stroke and death was Ϸ3 times higher among comparable studies in which outcome was assessed by a neurologist (4.3% vs 1.5%, PϽ0.001). 28 If the risk of stroke after intensive contemporary medical intervention alone is now lower than in large, randomized, controlled trials, it is highly unlikely than any overall benefit from surgery would remain. Some useful data should be available in future from the SPACE II Trial, which will randomize patients with asymptomatic carotid artery stenosis to CAE versus stenting versus medical intervention alone. 颈动脉或周围动脉 ) 手术 [18] 。一项 SPARCL 亚组研 究的结果表明，随机分配至阿托伐他汀组的患者进 行择期颈动脉血管重建术的比例减少了 56% [19] 
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的无症状性颈动脉狭窄。这 101 例中，75 例表现为 对侧颈内动脉 TIA 或卒中 ( 相对于后循环事件而言 )， 其中 33 例同时存在对侧 ≥50% 的症状性狭窄，3 例 存在症状性颈动脉闭塞。临床特征见表 1。69 例患 者无症状颈动脉狭窄率在 50%-69%，32 例患者无症 状颈动脉狭窄率在 70%-99%。 平 均 随 访 时 间 为 3 年 ( 范 围 自 1 至 84 个 月 )， 发生卒中或死亡之前共完成 301 患者 -年的随访。 33 例狭窄 ≥50% 的症状性合并无症状性颈动脉狭窄 患者中， 25 例患者在随访早期接受了 CEA 手术治疗。 仅有 1 例患者在随访期间因无症状颈动脉狭窄接受 了 CEA 手术，进行支架成形术的患者数为 0。在观 察期间，2 例患者接受了冠状动脉搭桥手术。 表 2 显示了在第 1、12、24 个月随访时患者的 药物使用情况和血压控制情况。几乎所有患者 (97%)随 访期 间在无 症 状狭窄 区 域 发生 了 6 例 缺 血 性 事 件 ：1 例 小 卒 中 ( 最 初 为 50% 的 狭 窄 )，5 例 TIA(2 例 最 初 狭 窄 为 50%-69% ；3 例 最 初 狭 窄 为 70%-99%)。平均每年发生任一同侧颈动脉区域的缺
